Clinical Trial Update: Comparison of Three Liraglutide Formulations in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 trial compares three liraglutide formulations in healthy volunteers to assess pharmacokinetics and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• SAXENDA (liraglutide)
• Victoza (Liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED